Stay updated on Nivolumab + HF10 for Resectable Melanoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab + HF10 for Resectable Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab + HF10 for Resectable Melanoma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Added Melanoma as a related topic and MedlinePlus Genetics as related topics on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-12-10T00:40:23.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    Added a new site revision entry: Revision: v3.3.2. Removed the Melanoma topic and the related MedlinePlus Genetics topic, as well as the older Revision: v3.2.0.
    Difference
    0.2%
    Check dated 2025-11-25T14:15:45.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    Removal of the government funding/operating status banner from the bottom of the page. This change does not affect the study details, eligibility criteria, or results; to avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-18T07:28:17.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    A MedlinePlus Genetics related topic for Melanoma has been added to the page. This is a minor informational enhancement that does not affect study details or user workflows.
    Difference
    0.9%
    Check dated 2025-10-27T21:06:10.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Removed a MedlinePlus Genetics topic: Melanoma.
    Difference
    0.2%
    Check dated 2025-10-13T12:27:22.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    Update: Version bumped to v3.2.0 and a new government funding operating-status notice added; previous v3.1.0 revision removed.
    Difference
    3%
    Check dated 2025-10-06T08:25:09.000Z thumbnail image

Stay in the know with updates to Nivolumab + HF10 for Resectable Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab + HF10 for Resectable Melanoma Clinical Trial page.